Artivion Announces Completion of Enrollment in PERSEVERE Trial PR Newswire ATLANTA, Nov. 9, 2023 ATLANTA, Nov...
Artivion to Participate in Upcoming Investor Conferences PR Newswire ATLANTA, Nov. 8, 2023 ATLANTA, Nov. 8...
Artivion Reports Third Quarter 2023 Financial Results PR Newswire ATLANTA, Nov. 2, 2023 Third Quarter and...
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results PR...
Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve...
Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European...
Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference PR Newswire ATLANTA, Sept...
Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase PR Newswire ATLANTA, Sept. 14...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.